Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly return on assets; no daily interpolation. Q4 FY2025 (2025-12-31): -23.44%.
RETURN ON ASSETS (ROA)
N/A
RETURN ON ASSETS (ROA) AVG TTM
7.76%
RETURN ON ASSETS (ROA) AVG 3Y
8.55%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
NewGenIvf Group Limited
Market Cap
$6235.00
Return on Assets (ROA)
N/A
TTM Avg
7.76%
3Y Avg
8.55%
5Y Avg
N/A
Market Cap
$30054.00
Return on Assets (ROA)
-73.13%
TTM Avg
-134.69%
3Y Avg
-84.14%
5Y Avg
-80.58%
Market Cap
$30562.00
Return on Assets (ROA)
-25.95%
TTM Avg
-14.21%
3Y Avg
-20.62%
5Y Avg
-11.50%
Market Cap
$61172.00
Return on Assets (ROA)
-736.88%
TTM Avg
-394.32%
3Y Avg
-295.91%
5Y Avg
-223.09%
Market Cap
$71053.00
Return on Assets (ROA)
-46.60%
TTM Avg
-181.35%
3Y Avg
-132.03%
5Y Avg
-98.15%
Market Cap
$95475.00
Return on Assets (ROA)
N/A
TTM Avg
-12.82%
3Y Avg
-1135.32%
5Y Avg
-756.46%
Market Cap
$106970.00
Return on Assets (ROA)
-328.73%
TTM Avg
-369.72%
3Y Avg
-216.98%
5Y Avg
-169.99%
Market Cap
$252756.00
Return on Assets (ROA)
-159.79%
TTM Avg
-110.26%
3Y Avg
-72.69%
5Y Avg
-81.04%
Market Cap
$378849.00
Return on Assets (ROA)
-60.35%
TTM Avg
-77.33%
3Y Avg
-83.27%
5Y Avg
-755.53%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewGenIvf Group Limited (NIVF) | $6235.00 | N/A | 7.76% | 8.55% | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30054.00 | -73.13% | -134.69% | -84.14% | -80.58% |
| Zhongchao Inc. (ZCMD)vs › | $30562.00 | -25.95% | -14.21% | -20.62% | -11.50% |
| Akanda Corp. (AKAN)vs › | $61172.00 | -736.88% | -394.32% | -295.91% | -223.09% |
| PRF Technologies Ltd. (PRFX)vs › | $71053.00 | -46.60% | -181.35% | -132.03% | -98.15% |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | N/A | -12.82% | -1135.32% | -756.46% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $106970.00 | -328.73% | -369.72% | -216.98% | -169.99% |
| SciSparc Ltd. (SPRC)vs › | $252756.00 | -159.79% | -110.26% | -72.69% | -81.04% |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | -60.35% | -77.33% | -83.27% | -755.53% |
| Niki BioSolutions, Inc. (NIKI)vs › | $385197.00 | -7.29% | -16.88% | -23.60% | -32.13% |
ROA
N/A
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 30.19% |
| 2024-12-31 | -14.67% |
| 2023-12-31 | 2.90% |
| 2022-12-31 | 15.79% |
| 2021-12-31 | -0.04% |
